Opthea Limited reports a Return on Equity (ROE) of 0.00%.

What is OPTEY's dividend yield?

Opthea Limited offers a dividend yield of 0.00%.

What is OPTEY's Quality Score?

Our AI rates OPTEY's overall financial quality at 38 out of 100, based on profitability, growth, debt and earnings stability.

Is now a good time to buy OPTEY?

Our AI Timing Score for OPTEY is 3 out of 100, indicating the relative attractiveness of buying at the current price using technical and momentum signals.

Which sector does OPTEY belong to?

Opthea Limited is classified under the Healthcare >> Biotechnology sector on the NASDAQ exchange

Opthea Limited (OPTEY) Stock Price

Stock Check Daily update data at 8:30 AM
(Price: 2026-07-15 | FS: 2025-09-30)

OPTEY AI Analysis Summary

Our AI summary for OPTEY: Opthea Limited (NASDAQ), Healthcare >> Biotechnology sector. The stock currently trades at a P/E of 0.00, ROE of 0.00%, a dividend yield of 0.00%. Its financial Quality Score stands at 38/100 — fundamentals below the market average. The AI Timing Score is 3/100 — most technical signals do not support an entry at this point. All scores are recomputed automatically after each market close from official exchange data. This is systematically generated analysis, not personalized investment advice.

OPTEY

Opthea Limited

US:NASDAQ STOCK Healthcare >> Biotechnology

USD 0.03

0.01 (70.00%) Day Change

Watchlist Portfolio Compare Chart

-0.93

D/E

0.0%

ROE

0.0%

ROA

0.00%

Div Yield

Data partially updated

OPTHEA LIMITED
TYPE: STOCK
MARKET: NASDAQ

Compare Watchlist Myport

USD 0.03 Price 0.01 (70.00%) Day Change	NEWS SCORE: N/A

OPTEY, the overall quality is not good ( Quality = 38) and the timing to buy is ...(Sign In to See)...

No price data to display chart for the last 3-months of this stock

38 QUALITY

Signal: UNDERPERFORM

Signal Description: Company financial health is Not Good

Reason: ROE is relatively low.
ROA is relatively low.
Acceleration of ROE growth rate is below our criteria.
Negative growth of ROE in the last year.
ROE is decreasing significantly
Growth of ROA was below our criteria in the last year.
Net profit margin is relatively low.
Historical net profit margin is relatively low.

88 Sign in

TIMING

Signal: OUTPERFORM

Signal Descri...: Good

Reason: Momentum indicators aligned on the daily timeframe

Unlock timing signals and detailed reasons

In details, quality factors are not good , financial health is not good , and ability to make profit is not quite good , ...

Quality Factors

45%

In Recommendations?	Not in any sections
Select Rate	0.00 From 30 days period
Watch Rate	0.00 From 30 days period
News Score	N/A
Magic Formula Rank by ROA	N/A
Magic Formula Rank by ROE	N/A
Magic Formula Rank by ROIC	N/A
Price	0.03
PBV / Sector	-0.03 / 5.20
Earning Per Share	N/A

PE / Sector	N/A / 19.97
PEG or PE/Growth / Sector	N/A / 1.22
Average 1M Daily Value	1407.162450000000
Average 1W Daily Value	1413.768200000000

Timing Factors

85%

MACD	SIGN IN
MACD Signal	SIGN IN
MACD Divergence	SIGN IN
RSI	SIGN IN
Stochastic Oscillator K	SIGN IN
Stochastic Oscillator D	SIGN IN
ADX	SIGN IN
Avg 5 day Timing Score	SIGN IN

Financial Health

41%

DE / Sector	SIGN IN
DE Average / Sector	SIGN IN
DE Change Average (%) / Sector	SIGN IN
Current Ratio / Sector	SIGN IN
Current Ratio Average / Sector	SIGN IN
Current Ratio Change Average (%) / Sector	SIGN IN
Quick Ratio / Sector	SIGN IN
Quick Ratio Average / Sector	SIGN IN
Quick Ratio Change Average (%) / Sector	SIGN IN
FCF/Share / Sector	SIGN IN
FCF/Share Average / Sector	SIGN IN
FCF/Share Change Average (%) / Sector	SIGN IN

Ability to Make Profit

56%

GPM (%) / Sector	SIGN IN
GPM Average (%) / Sector	SIGN IN
GPM Change Average (%) / Sector	SIGN IN
OPM (%) / Sector	SIGN IN
OPM Average (%) / Sector	SIGN IN
OPM Change Average (%) / Sector	SIGN IN
NPM (%) / Sector	N/A / 98.71
NPM Average (%) / Sector	-265,418.79 / -1,721.76
NPM Change Average (%) / Sector	58.00 / 5,211.62 GREAT
Asset Turnover / Sector	SIGN IN
Asset Turnover Average / Sector	SIGN IN
Asset Turnover Change Average (%) / Sector	SIGN IN
ROA (%) / Sector	N/A / 27.02
ROA Average (%) / Sector	-175.58 / -368.17
ROA Change Average (%) / Sector	39.96 / 5,404.12 GREAT
ROE (%) / Sector	N/A / 3.47
ROE Average (%) / Sector	522.59 / 6.51 GREAT
ROE Change Average (%) / Sector	-404.70 / 2,128.13
ROIC (%) / Sector	SIGN IN
ROIC Average (%) / Sector	SIGN IN
ROIC Change Average (%) / Sector	SIGN IN

Return to Investors

Dividend (%) / Sector	N/A / 0.04
Dividend Average (%) / Sector	N/A / 17.04
Dividend Change Average (%) / Sector	N/A / -1.75

Registration Details

Analyze Date	2026-08-01 08:00:17
Symbol	OPTEY
Name	OPTHEA LIMITED
Sector	Healthcare >> Biotechnology
Market	NASDAQ
Listed Shares	171.00 M
Par Value	N/A
Calculated From	Quarter
Sign	N/A
Market Cap (M.USD) / Sector Average	5.81 / 9,903.94

News, Concensus, ...

Estimation Consensus	See at WSJ.com
Full details	See at WSJ.com
Chart	See in Chart feature
News	See at Yahoo Finance

Address: Level 9, Melbourne, VIC, Australia, 3000

Phone: 61 3 9826 0399

Website: https://ceryvyn.com

Employees: -

Sector: Healthcare >> Biotechnology

Description: Ceryvyn Therapeutics Limited, a clinical-stage biopharmaceutical company, researches and develops therapeutic products based on targeting vascular endothelial growth factors (VEGF) C, D and R3 in Australia and the United States. The company's pipeline includes Sozinibercept, which is in phase 3 to treat wet age-related macular degeneration (Wet AMD), as well as in phase 2 to treat diabetic macular edema (DME). It serves the biotechnology and healthcare industries. The company was formerly known as Opthea Limited and changed its name to Ceryvyn Therapeutics Limited in July 2026. Ceryvyn Therapeutics Limited was incorporated in 1984 and is headquartered in Melbourne, Australia.